Neurodegenerative Diseases Related Content

A new study by the University of Eastern Finland finds that a blood test could help to diagnose patients with frontotemporal dementia.

Indiana University School of Medicine researchers are attempting to use magnetic nanoparticles to develop a cure for neurological disorders from epilepsy to Alzheimer's - without any invasive or genetic treatment.

Dr Rutger Zietsma – CEO at Manus Neurodynamica Ltd – and PD Dr Angela Deutschländer share their vision on earlier diagnosis and objective symptom tracking with the NeuroMotor PenTM.

Professor of Neurology Thomas Gasser, JPND’s Scientific Advisory Board Chair and Director of the Department of Neurodegenerative Diseases, shares in an interview JPND’s innovative research and collaboration efforts in the universal race against Alzheimer’s and Parkinson’s diseases.

Dr Roderick Corriveau, PhD from the National Institute of Neurological Disorders & Stroke, part of the National Institutes of Health in the U.S., details the importance of understanding the many possible paths to dementia.

Doctors Osama Al Dalahmah and James E. Goldman discuss their work on single Nuclei RNA sequencing of Huntington’s disease brain tissues.

Here, Professor Pamela Lein at University of California, Davis, discusses the relatively unexplored issue of the human brain as a target of COVID-19.

Dr. James E Goldman and Dr. Osama Al-Dalahmah from the Department of Pathology and Cell Biology at Columbia University, provide an in-depth perspective on Huntington’s disease (HD) research.

Dr Timothy Kwok, Professor at The Chinese University of Hong Kong, shares the development of the Electronic Cognitive Screen (EC-Screen) for population screening of dementia in older people.

Researchers are investigating how everyday pain impacts memory - specifically, how do these daily experiences impact the way we think? 

JPND, the largest global collaborative initiative for neurodegenerative disease research, creates a major impact on neurodegenerative research funding in Europe.

Prof Monica Di Luca, President, European Brain Council, sheds light on brain conditions, mental and neurological alike, starting with comment on the burdens presented.

Over 350 million people suffer from arthritis pain globally, which means significant levels of opiates are used to manage the condition - but what if there was a less addictive treatment?

Daniel Berman from Nesta Challenges and Colin Capper at the Alzheimer’s Society focus here on dementia tech, including comment on overcoming barriers to innovation post-pandemic.

Dementia UK’s Head of Research and Publications, Dr Karen Harrison Dening, discusses her thoughts on the diagnosis of dementia and the impact of COVID-19 on this.

Researchers at Cambridge University found that over-activity in one brain region links depression, anxiety, and heart disease.

JPND - finding cures for neurodegenerative diseases and working to enable early diagnosis for early targeted treatments with worldwide collaboration.

The October 2020 edition of Open Access Government speaks about global government policy issues, such as health & social care, research & innovation, digital transformation, economic development, international development, environment, energy and equality.

Chairman for the global initiative EU Joint Programme – Neurodegenerative Disease Research (JPND) Professor Philippe Amouyel brings to light their innovative work in neurodegenerative disease research.

A new blood test shows promise in detecting Alzheimer’s as early as 20 years before the onset of cognitive impairment, according to researchers.